These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 310522)
1. Identification of the neuritogen for experimental allergic neuritis. Kadlubowski M; Hughes RA Nature; 1979 Jan; 277(5692):140-1. PubMed ID: 310522 [No Abstract] [Full Text] [Related]
2. Experimental allergic neuritis and Guillain-Barré syndrome: immune mechanisms. A short review. Hartung HP Acta Neurol Belg; 1994; 94(2):120-3. PubMed ID: 8036878 [No Abstract] [Full Text] [Related]
3. Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Zweiman B; Rostami A; Lisak RP; Moskovitz AR; Pleasure DE Neurology; 1983 Feb; 33(2):234-7. PubMed ID: 6600513 [TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Adelmann M; Linington C Neurochem Res; 1992 Sep; 17(9):887-91. PubMed ID: 1383842 [TBL] [Abstract][Full Text] [Related]
5. [Guillain-Barré syndrome. Current status]. Masson C Presse Med; 1983 Mar; 12(11):689-93. PubMed ID: 6188143 [TBL] [Abstract][Full Text] [Related]
6. P2-reactive T cells in inflammatory demyelination of the peripheral nerve. Rostami AM J Infect Dis; 1997 Dec; 176 Suppl 2():S160-3. PubMed ID: 9396703 [TBL] [Abstract][Full Text] [Related]
7. [Inflammatory demyelinating diseases if the peripheral nervous system: immunological concepts and experimental models]. Vass K; Lassmann H Wien Klin Wochenschr Suppl; 1991; 190():13-6. PubMed ID: 1771901 [TBL] [Abstract][Full Text] [Related]
9. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis. Vriesendorp FJ J Infect Dis; 1997 Dec; 176 Suppl 2():S164-8. PubMed ID: 9396704 [TBL] [Abstract][Full Text] [Related]
10. Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein. Brostoff SW; Levit S; Powers JM Nature; 1977 Aug; 268(5622):752-3. PubMed ID: 70758 [No Abstract] [Full Text] [Related]
16. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation. Koski CL Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928 [No Abstract] [Full Text] [Related]
17. Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Saida T; Saida K; Silberberg DH; Brown MJ Nature; 1978 Apr; 272(5654):639-41. PubMed ID: 643059 [No Abstract] [Full Text] [Related]
18. Association with autoimmune diseases and cellular immune response to the neuritogenic protein in Guillain-Barré syndrome. Abramsky O; Korn-Lubetzky I; Teitelbaum D Trans Am Neurol Assoc; 1980; 105():350-4. PubMed ID: 7348980 [No Abstract] [Full Text] [Related]
19. Pathogenesis of inflammatory demyelination: implications for therapy. Hartung HP Curr Opin Neurol; 1995 Jun; 8(3):191-9. PubMed ID: 7551118 [No Abstract] [Full Text] [Related]
20. Pathogenesis of early phase experimental allergic neuritis: daily monitoring of humoral and cellular immune response to peripheral nerve antigen. Molnár GK; Viljanen MK; Riekkinen PJ Acta Neurol Scand; 1979 Dec; 60(6):375-83. PubMed ID: 549444 [No Abstract] [Full Text] [Related] [Next] [New Search]